Antioxidant Effect of Fructus Ligustri Lucidi Aqueous Extract in Ovariectomized Rats Is Mediated through Nox4-ROS-NF-κB Pathway
Purpose: This study is designed to explore whether Fructus ligustri lucidi (FLL) exhibits antioxidant effect in ovariectomized (OVX) rats, and to identify the signaling pathway involved in this process.Methods: OVX rats were treated with FLL aqueous extract (3.5 g/kg) for 12 weeks. Serum, uteri, and...
Saved in:
Main Authors: | , , , , , , , , , , , , , , , , , , , |
---|---|
Format: | Book |
Published: |
Frontiers Media S.A.,
2017-05-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
MARC
LEADER | 00000 am a22000003u 4500 | ||
---|---|---|---|
001 | doaj_4e63eaeae1d84d3ba0a949d0aa9fccb6 | ||
042 | |a dc | ||
100 | 1 | 0 | |a Lili Wang |e author |
700 | 1 | 0 | |a Rufeng Ma |e author |
700 | 1 | 0 | |a Yubo Guo |e author |
700 | 1 | 0 | |a Jing Sun |e author |
700 | 1 | 0 | |a Haixia Liu |e author |
700 | 1 | 0 | |a Ruyuan Zhu |e author |
700 | 1 | 0 | |a Chenyue Liu |e author |
700 | 1 | 0 | |a Jun Li |e author |
700 | 1 | 0 | |a Lin Li |e author |
700 | 1 | 0 | |a Beibei Chen |e author |
700 | 1 | 0 | |a Liping Sun |e author |
700 | 1 | 0 | |a Jinfa Tang |e author |
700 | 1 | 0 | |a Dandan Zhao |e author |
700 | 1 | 0 | |a Fangfang Mo |e author |
700 | 1 | 0 | |a Jianzhao Niu |e author |
700 | 1 | 0 | |a Guangjian Jiang |e author |
700 | 1 | 0 | |a Min Fu |e author |
700 | 1 | 0 | |a Dieter Brömme |e author |
700 | 1 | 0 | |a Dongwei Zhang |e author |
700 | 1 | 0 | |a Sihua Gao |e author |
245 | 0 | 0 | |a Antioxidant Effect of Fructus Ligustri Lucidi Aqueous Extract in Ovariectomized Rats Is Mediated through Nox4-ROS-NF-κB Pathway |
260 | |b Frontiers Media S.A., |c 2017-05-01T00:00:00Z. | ||
500 | |a 1663-9812 | ||
500 | |a 10.3389/fphar.2017.00266 | ||
520 | |a Purpose: This study is designed to explore whether Fructus ligustri lucidi (FLL) exhibits antioxidant effect in ovariectomized (OVX) rats, and to identify the signaling pathway involved in this process.Methods: OVX rats were treated with FLL aqueous extract (3.5 g/kg) for 12 weeks. Serum, uteri, and tibias were harvested from the rats and the levels of total antioxidant capacity (TAC), nitric oxide (NO), malondialdehyde (MDA), 8-hydroxy-desoxyguanosine (8-OHdG), and superoxide dismutase (SOD) were determined. Changes in the levels of NF-κB-p65, phosphorylation of NF-κB-p65 (NF-κB-pp65), NF-κB inhibitor alpha (IκBα), phosphorylation of IκBα (p-IκBα), and NADPH oxidase 4 (Nox4) in uteri and tibias were determined by western blot, immunofluorescent and immunohistochemical analysis, respectively. In addition, the expression of cytochrome C (Cyto-C) and B-cell lymphoma-2 (Bcl-2) were determined in the tibias of rats. Histopathological changes in the bones were evaluated by hematoxylin-eosin staining. Bone mineral density (BMD) was determined in rat femurs by dual X-ray absorptiometry.Results: Treatment of OVX rats with FLL aqueous extract improved redox homeostasis by increasing the levels of TAC and NO as well as decreasing the levels of MDA and 8-OHdG in serum, tibias, and uteri. Further, FLL extract also downregulated the expression of Nox4, NF-κB-p65, NF-κB-pp65, and p-IκBα in the uteri and tibias. Furthermore, administration of FLL-OVX rats increased Bcl-2 expression and prevented cytoplasmic release of mitochondrial Cyto-C in the tibias. In addition, FLL treatment also improved bone microstructure and increased cortical bone thickness as well as increased BMD values in the femurs of OVX rats.Conclusions: FLL treatment may suppress oxidative stress response in OVX rats via regulating the Nox4/ROS/NF-κB signaling pathway. These results suggest the potential of using FLL as a natural antioxidant agent in preventing the development of osteoporosis. | ||
546 | |a EN | ||
690 | |a Fructus Ligustri Lucidi | ||
690 | |a ovariectomy | ||
690 | |a NADPH oxidase 4 (Nox4) | ||
690 | |a nuclear factor kappa B (NF-κB) | ||
690 | |a oxidative stress | ||
690 | |a Therapeutics. Pharmacology | ||
690 | |a RM1-950 | ||
655 | 7 | |a article |2 local | |
786 | 0 | |n Frontiers in Pharmacology, Vol 8 (2017) | |
787 | 0 | |n http://journal.frontiersin.org/article/10.3389/fphar.2017.00266/full | |
787 | 0 | |n https://doaj.org/toc/1663-9812 | |
856 | 4 | 1 | |u https://doaj.org/article/4e63eaeae1d84d3ba0a949d0aa9fccb6 |z Connect to this object online. |